BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/19/2016 9:54:00 AM | Browse: 1978 | Download: 3007
 |
Received |
|
2016-01-19 17:10 |
|
Peer-Review Started |
|
2016-01-19 17:33 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-03-07 11:00 |
|
Revised |
|
2016-03-16 04:21 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-03-24 11:22 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2016-03-30 16:48 |
|
Articles in Press |
|
2016-03-30 16:48 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-04-06 10:46 |
|
Publish the Manuscript Online |
|
2016-05-17 10:45 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Allergy |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Christine M Hunt, Lauren A Beste, Elliott Lowy, Ayako Suzuki, Cynthia A Moylan, Hans L Tillmann, George N Ioannou, Joseph K Lim, Michael J Kelley and Dawn Provenzale |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Veterans Affairs (VA) Cooperative Studies Program Epidemiology Center-Durham, the Puget Sound VA Health Care System, and the VA Office of Public Health and Human Health Pathogens (partly) |
|
|
| Corresponding Author |
Christine M Hunt, MD, MPH, Adjunct Associate Professor of Medicine, Department of Medicine, Duke University School of Medicine, Duke University, 00550 Hospital South, Durham, NC 27710,
United States. christine.hunt@va.gov
|
| Key Words |
Hepatitis B; Hepatitis B reactivation; Anti-CD20 antibody; Rituximab; Lymphoma; Chemotherapy; Hepatitis B antivirals; Vaccination; Veteran |
| Core Tip |
Prior to anti-CD20 antibody (Ab) treatment in 2014, 61%-73% of 19304 Veterans had hepatitis B virus (HBV) tests. Of these, 11% tested were positive for hepatitis B surface antigen or core antibody and at risk for reactivation; ≤ 37% of these HBV+ patients received HBV antivirals during anti-CD20 Ab and follow-up. HBV+ patients had significantly higher hepatitis rates than HBV-. Among pretreatment HBV- patients, about 1 in 300 tested suffered acute hepatitis during anti-CD20 Ab and 12 mo follow-up. Electronic health record algorithms to increase HBV testing, antiviral use and vaccination will likely improve outcomes with anti-CD20 Ab treatment.
|
| Publish Date |
2016-05-17 10:45 |
| Citation |
Hunt CM, Beste LA, Lowy E, Suzuki A, Moylan CA, Tillmann HL, Ioannou GN, Lim JK, Kelley MJ, Provenzale D. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration. World J Gastroenterol 2016; 22(19): 4732-4740
|
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i19/4732.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i19.4732 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
